Factors influencing Leishmania major infection in IL-4-deficient BALB/c mice

P Kropf1, S Herath, V Weber

  • 1Imperial College London, Faculty of Medicine, Division of Investigative Science, Department of Immunology, London, UK. p.kropf@imperial.ac.uk

Parasite Immunology
|December 4, 2003
PubMed

Insights

Investigating Leishmania major infection in IL-4-deficient mice revealed that parasite arginase activity and host age influence disease progression. Older mice showed transient resistance, while parasite strain impacted lesion severity.

Area of Science:

  • Immunology
  • Parasitology
  • Genetics

Background:

  • The outcome of Leishmania major infection in IL-4-deficient BALB/c mice is debated, with conflicting reports on resistance versus progressive disease.
  • Previous studies reported differing results, necessitating an investigation into factors influencing Leishmania major infection in these mice.

Purpose of the Study:

  • To identify factors contributing to the variable outcomes of Leishmania major infection in IL-4-deficient BALB/c mice.
  • To resolve discrepancies in the literature regarding the role of IL-4 in Leishmania major infection control.

Main Methods:

  • Tested different lines of IL-4-deficient BALB/c mice to rule out genetic background differences.
  • Infected mice with various Leishmania major isolates to assess parasite strain impact.
  • Evaluated the influence of host age on infection course.
  • Measured arginase activity in parasites.

Main Results:

  • Differences in infection outcomes were not attributable to the genetic origin of embryonic stem cells used for IL-4 gene disruption.
  • No Leishmania major isolates were cleared, though some caused milder pathology correlated with reduced parasite arginase activity.
  • Older IL-4-deficient mice exhibited transient resistance to infection.

Conclusions:

  • Host age and parasite arginase activity are key factors influencing the non-healing phenotype in IL-4-deficient BALB/c mice.
  • These factors help explain the controversial outcomes reported in previous studies of Leishmania major infection.